E
Elizabeth C Okafor
Researcher at University of Minnesota
Publications - 15
Citations - 1938
Elizabeth C Okafor is an academic researcher from University of Minnesota. The author has contributed to research in topics: Hydroxychloroquine & Randomized controlled trial. The author has an hindex of 10, co-authored 14 publications receiving 1474 citations. Previous affiliations of Elizabeth C Okafor include McGill University & University of Missouri.
Papers
More filters
Journal ArticleDOI
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
David R. Boulware,Matthew F Pullen,Ananta S. Bangdiwala,Katelyn A Pastick,Sarah M Lofgren,Elizabeth C Okafor,Caleb P Skipper,Alanna A Nascene,Melanie R. Nicol,Mahsa Abassi,Nicole W. Engen,Matthew P. Cheng,Derek LaBar,Sylvain A. Lother,Lauren J. MacKenzie,Glen Drobot,Nicole Marten,Ryan Zarychanski,Lauren E. Kelly,Ilan S. Schwartz,Emily G. McDonald,Radha Rajasingham,Todd C. Lee,Kathy H. Hullsiek +23 more
TL;DR: After high-risk or moderate-risk exposure to Covid-19, hydroxychloroquine did not prevent illness compatible with Covid -19 or confirmed infection when used as postexposure prophylaxis within 4 days after exposure.
Journal ArticleDOI
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial.
Caleb P Skipper,Katelyn A Pastick,Nicole S Engen,Ananta S Bangdiwala,Mahsa Abassi,Sarah M Lofgren,Darlisha A. Williams,Elizabeth C Okafor,Matthew F Pullen,Melanie R. Nicol,Alanna A Nascene,Katherine Huppler Hullsiek,Matthew P. Cheng,Darlette Luke,Sylvain A. Lother,Lauren J. MacKenzie,Glen Drobot,Lauren E. Kelly,Ilan S. Schwartz,Ryan Zarychanski,Emily G. McDonald,Todd C. Lee,Radha Rajasingham,David R. Boulware +23 more
TL;DR: This randomized, double-blind, placebo-controlled trial evaluated effects of oral hydroxychloroquine on symptoms and disease severity in adult outpatients with early COVID-19.
Journal ArticleDOI
Review: Hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19)
Katelyn A Pastick,Elizabeth C Okafor,Fan Wang,Sarah M Lofgren,Caleb P Skipper,Melanie R. Nicol,Matthew F Pullen,Radha Rajasingham,Emily G. McDonald,Todd C. Lee,Ilan S. Schwartz,Lauren E. Kelly,Sylvain A. Lother,Oriol Mitjà,Emili Letang,Mahsa Abassi,David R. Boulware +16 more
TL;DR: A rapid narrative review and call for additional randomized controlled trial evidence prior to the widespread incorporation of hydroxychloroquine and chloroquine into national and international treatment guidelines are called for.
Journal ArticleDOI
Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial
Radha Rajasingham,Ananta S Bangdiwala,Melanie R. Nicol,Caleb P Skipper,Katelyn A Pastick,Margaret L Axelrod,Matthew F Pullen,Alanna A Nascene,Darlisha A. Williams,Nicole Engen,Elizabeth C Okafor,Brian I. Rini,Ingrid A. Mayer,Emily G. McDonald,Todd C. Lee,Peter Li,Lauren J. MacKenzie,Justin M. Balko,Stephen J. Dunlop,Katherine Huppler Hullsiek,David R. Boulware,Sarah M Lofgren,Covid Prep team +22 more
TL;DR: Pre-exposure prophylaxis with hydroxychloroquine once or twice weekly did not significantly reduce laboratory-confirmed CO VID-19 or COVID-19–compatible illness among healthcare workers.
Posted ContentDOI
Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial.
Radha Rajasingham,Ananta S Bangdiwala,Melanie R. Nicol,Caleb P Skipper,Katelyn A Pastick,Margaret L Axelrod,Matthew F Pullen,Alanna A Nascene,Darlisha A. Williams,Nicole Engen,Elizabeth C Okafor,Brian I. Rini,Ingrid A. Mayer,Emily G. McDonald,Todd C. Lee,Peter Li,Lauren J. MacKenzie,Justin M. Balko,Stephen J. Dunlop,Katherine Huppler Hullsiek,David R. Boulware,Sarah M Lofgren +21 more
TL;DR: Pre-exposure prophylaxis with hydroxychloroquine once or twice weekly did not significantly reduce laboratory-confirmed Covid-19 or Covid -19-compatible illness among healthcare workers.